These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7624111)

  • 41. Radioimmunodetection of colorectal carcinoma with 111In-labelled monoclonal antibody IVP ZCE 025 (a tissue culture-produced anti-CEA MAb).
    Abdel-Nabi H; Doerr RJ; Evans NH; Farrell EE; Chan HW; Balu D; Gona J; Schweighardt S
    Nucl Med Commun; 1994 Feb; 15(2):81-93. PubMed ID: 8170642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
    Hnatowich DJ; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin TW; Brill AB
    Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.
    Quadri SM; Lai J; Mohammadpour H; Vriesendorp HM; Williams JR
    J Nucl Med; 1993 Dec; 34(12):2152-9. PubMed ID: 8254403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-alpha-2b immunoconjugate for improving immunoscintigraphy and immunotherapy.
    Pallela VR; Rao SP; Thakur ML
    J Nucl Med; 2000 Jun; 41(6):1108-13. PubMed ID: 10855643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.
    Yazaki PJ; Kassa T; Cheung CW; Crow DM; Sherman MA; Bading JR; Anderson AL; Colcher D; Raubitschek A
    Nucl Med Biol; 2008 Feb; 35(2):151-8. PubMed ID: 18312824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.
    Delgado C; Pedley RB; Herraez A; Boden R; Boden JA; Keep PA; Chester KA; Fisher D; Begent RH; Francis GE
    Br J Cancer; 1996 Jan; 73(2):175-82. PubMed ID: 8546903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
    Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
    Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
    Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
    Pedley RB; Boden JA; Boden R; Dale R; Begent RH
    Br J Cancer; 1993 Jul; 68(1):69-73. PubMed ID: 8318423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.
    Perälä-Heape M; Vihko P; Laine A; Heikkilä J; Vihko R
    Eur J Nucl Med; 1991; 18(5):339-45. PubMed ID: 1936042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiolocalisation of an anti-CEA monoclonal antibody (FO23C5) and its fragments in a colon carcinoma xenograft model.
    Rowlinson G; Paganelli G; Snook D; Epenetos AA
    Int J Biol Markers; 1988; 3(4):259-64. PubMed ID: 3235854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.
    Faivre-Chauvet A; Gestin JF; Mease RC; Sai-Maurel C; Thédrez P; Slinkin M; Meinken GE; Srivastava SC; Chatal JF
    Nucl Med Biol; 1993 Aug; 20(6):763-71. PubMed ID: 8401377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
    Pedley RB; Boden JA; Boden R; Begent RH; Turner A; Haines AM; King DJ
    Br J Cancer; 1994 Dec; 70(6):1126-30. PubMed ID: 7981064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiolocalization of pancreatic carcinoma xenografts in nude mice with radiolabeled chimeric Fab fragments of anti-carcinoembryonic antigen monoclonal antibody A10.
    Kamigaki T; Yamamoto M; Ohyanagi H; Saitoh Y
    Pancreas; 1995 Apr; 10(3):258-64. PubMed ID: 7624303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio.
    Sandström K; Haylock AK; Spiegelberg D; Qvarnström F; Wester K; Nestor M
    Int J Oncol; 2012 May; 40(5):1525-32. PubMed ID: 22307465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
    Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
    Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative tumour localization of antibody fragments and intact IgG in nude mice bearing a CEA-producing human colon tumour xenograft.
    Harwood PJ; Boden J; Pedley RB; Rawlins G; Rogers GT; Bagshawe KD
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1515-22. PubMed ID: 3830730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.